Event Details

!MORE SPACES ADDED!



Overview

This is the fourth in the series of webinars from The Estimands Academy for Trial Teams. We will build on the concepts and case studies previously discussed, recognizing the benefits of following the estimand framework (ICH E9 (R1)). A case study in heart failure will be presented from the perspective of multiple stakeholders. Topics covered will include constructing estimands for different stakeholder questions of interest including how to develop transparent estimands for product labels.


The targeted learning outcomes are as follows:

• To apply the estimand framework to a challenging realistic setting

• To appreciate the different stakeholder views when determining estimands

• To understand the relative merits of different strategies for intercurrent events

• Understanding implementation challenges and possible solutions


Time-zones

14:00-15:30 BST | 15:00-16:30 CEST | 09:00-10:30 EST


Who is this event intended for? Clinicians, Regulators, Investigators, Academics, members of Ethics Committees, Statisticians and health technology assessors.

What is the benefit of attending? Attendees will have the opportunity to hear the perspectives of a variety of stakeholders in determining estimands, in turn understanding more about challenges and possible solutions when applying the framework to a challenging realistic setting.

Tickets

PSI Member
Member Price Complimentary
PSI Non-Member
Standard Price Complimentary

Speakers

  • Judith Anzures-Cabrera (Principal Statistical Scientist at Roche Products Ltd)

    Judith Anzures-Cabrera

    Principal Statistical Scientist at Roche Products Ltd

  • Nikhil Kamath (Group Medical Director and Global Development Leader of Roche)

    Nikhil Kamath

    Group Medical Director and Global Development Leader of Roche

  • Antonia Morga (Global Health Economics and Outcome Research Director of Astellas Pharma Global Development)

    Antonia Morga

    Global Health Economics and Outcome Research Director of Astellas Pharma Global Development

  • David Wright (Head of Statistical Innovation at AstraZeneca)

    David Wright

    Head of Statistical Innovation at AstraZeneca

  • Sue McKendrick (Statistical Science Director of PPD Global Ltd)

    Sue McKendrick

    Statistical Science Director of PPD Global Ltd

Documents

EFPIA _proposing_estimands_from_different_perspectives_webinar_final.pdfdownload

Community

Connect with 869 people attending this event